February 05, 2016
Supernus Pharmaceuticals Inc. won a partial victory Friday in its bid to stop Actavis Inc. from bringing a generic version of the epilepsy drug Oxtellar XR to market when a New Jersey federal judge ruled the planned generic would infringe two Supernus patents.
November 18, 2015
Actavis Inc. copied formulas for a novel anti-seizure drug that took Supernus Pharmaceuticals Inc. years and millions of dollars to develop and market, according to testimony Wednesday as the the companies' patent infringement trial began in New Jersey federal court.
November 16, 2015
A New Jersey federal judge about to preside over a pharmaceutical patent infringement trial has agreed to entertain defendant Actavis Inc.'s requests to bar trade secrets and other sensitive information about its anti-seizure drug from being aired in a public courtroom.